MY135776A - PYRAZOLO [3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS - Google Patents

PYRAZOLO [3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS

Info

Publication number
MY135776A
MY135776A MYPI20033510A MY135776A MY 135776 A MY135776 A MY 135776A MY PI20033510 A MYPI20033510 A MY PI20033510A MY 135776 A MY135776 A MY 135776A
Authority
MY
Malaysia
Prior art keywords
formula
optionally substituted
pyrazolo
compound
inhibitors
Prior art date
Application number
Inventor
David George Allen
Mika Kristian Lindvall
Charlotte Jane Mitchell
Alison Judith Redgrave
Naimisha Trivedi
Peter Ward
Diane Mary Coe
Caroline Mary Cook
Michael Dennis Dowle
Christopher David Edlin
Julie Nicole Hamblin
Martin Redpath Johnson
Paul Spencer Jones
Richard Graham Knowles
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0221455A external-priority patent/GB0221455D0/en
Priority claimed from GBGB0230045.7A external-priority patent/GB0230045D0/en
Priority claimed from GB0306595A external-priority patent/GB0306595D0/en
Priority claimed from GB0308017A external-priority patent/GB0308017D0/en
Priority claimed from GB0319708A external-priority patent/GB0319708D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MY135776A publication Critical patent/MY135776A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE INVENTION RELATES TO A COMPOUND OF FORMULA (I) OR A SALT THEREOF: WHEREIN: R1 IS C1-4ALKYL, C1-3FLUOROALKYL, -CH2CH2OH OR -CH2CH2CO2C1-2A1KYL; R2 IS A HYDROGEN ATOM (H), METHYL OR C1 FLUOROALKYL; R3 IS OPTIONALLY SUBSTITUTED C3-8CYCLOALKYL OR OPTIONALLY SUBSTITUTED MONO-UNSATURATED-C5-7CYCLOALKENYL OR AN OPTIONALLY SUBSTITUTED HETEROCYCLIC GROUP OF SUB-FORMULA (AA), (BB) OR (CC); IN WHICH N1 AND N2 INDEPENDENTLY ARE 1 OR 2; AND IN WHICH Y IS O, S, SO2, OR NR10; OR R3 IS A BICYCLIC GROUP (DD) OR (EE): AND WHEREIN X IS NR4R5 OR OR5A.THE COMPOUNDS ARE PHOSPHODIESTERASE (PDE) INHIBITORS, IN PARTICULAR PDE4 INHIBITORS.ALSO PROVIDED IS THE USE OF A COMPOUND OF FORMULA (I), OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF,IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND/OR PROPHYLAXIS OF AN INFLAMMATORY AND/OR ALLERGIC DISEASE IN A MAMMAL SUCH AS A HUMAN, FOR EXAMPLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), ASTHMA, OR ALLERGIC RHINITIS.
MYPI20033510 2002-09-16 2003-09-15 PYRAZOLO [3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS MY135776A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0221455A GB0221455D0 (en) 2002-09-16 2002-09-16 Compounds
GBGB0230045.7A GB0230045D0 (en) 2002-12-23 2002-12-23 Compounds
GB0306595A GB0306595D0 (en) 2003-03-21 2003-03-21 Compounds
GB0308017A GB0308017D0 (en) 2003-04-07 2003-04-07 Compounds
GB0319708A GB0319708D0 (en) 2003-08-21 2003-08-21 Compounds

Publications (1)

Publication Number Publication Date
MY135776A true MY135776A (en) 2008-06-30

Family

ID=39430842

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20033510 MY135776A (en) 2002-09-16 2003-09-15 PYRAZOLO [3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS

Country Status (3)

Country Link
AR (1) AR041195A1 (en)
MY (1) MY135776A (en)
TW (1) TWI283678B (en)

Also Published As

Publication number Publication date
AR041195A1 (en) 2005-05-04
TWI283678B (en) 2007-07-11
TW200404801A (en) 2004-04-01

Similar Documents

Publication Publication Date Title
WO2004024728A3 (en) Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
TW200500364A (en) Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
TNSN08478A1 (en) Pyrazolo [3,4-d] pyrimidine derivatives useful to treat respiratory disorders
MX2007006497A (en) Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy.
WO2007040438A3 (en) Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders
NO20063340L (en) Pyrazole [3,4-B] pyridine compounds and their use as phosphodiesterase inhibitors
GEP20104973B (en) Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
DE60125026D1 (en) FLUOROISOCHINOLINE DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE
TW200602051A (en) Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
WO2006011024A3 (en) New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
WO2005021515A3 (en) Inhibitors of phosphodiesterase type-iv
WO2007095223A3 (en) Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases
CA2166721A1 (en) Bicyclic tetrahydro pyrazolopyridines
ATE370138T1 (en) NEW IMIDAZOPYRIDINES AND THEIR USE
WO2008070313A3 (en) 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
MX9504422A (en) Bicyclic tetrahydro pyrazolopyridines.
HK1127603A1 (en) Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
WO2003011274A3 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
MXPA03010162A (en) A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases.
TW200610529A (en) Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
MY135776A (en) PYRAZOLO [3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
WO2003011210A3 (en) Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase